Lyrica

E474930

Lyrica is a prescription medication (pregabalin) commonly used to treat nerve pain, fibromyalgia, and certain types of seizures.

Try in SPARQL Jump to: Statements Referenced by

Statements (48)

Predicate Object
instanceOf brand name drug
medication
affectsSystem central nervous system
approvedBy U.S. Food and Drug Administration NERFINISHED
approvedIn European Union NERFINISHED
United States NERFINISHED
availableAs extended-release tablet
oral capsule
oral solution
controlledSubstanceSchedule Schedule V in the United States
developedBy Pfizer NERFINISHED
FDAApprovalYear 2005
firstApprovedRegion European Union NERFINISHED
firstApprovedYear 2004
hasActiveIngredient pregabalin NERFINISHED
hasATCCode N03AX16
hasBlackBoxWarning risk of suicidal thoughts and behavior with antiepileptic drugs
hasCommonSideEffect blurred vision
difficulty concentrating
dizziness
dry mouth
peripheral edema
somnolence
weight gain
hasDrugClass anticonvulsant
antiepileptic drug
gabapentinoid
hasEliminationHalfLife about 6 hours in adults with normal renal function
hasGenericName pregabalin
hasRisk dependence potential
misuse potential
withdrawal symptoms on abrupt discontinuation
indicatedPopulation adults
isFormulationOf pregabalin
isNotRecommendedWith concurrent alcohol use due to additive CNS depression
legalStatus prescription only
mechanismOfAction binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system
pregnancyCategory Category C (US, historical)
primaryRouteOfElimination renal
requiresAdjustmentIn renal impairment
routeOfAdministration oral
treatsCondition diabetic peripheral neuropathy
fibromyalgia
focal seizures
neuropathic pain
neuropathic pain associated with spinal cord injury
partial-onset seizures
postherpetic neuralgia

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Pfizer developed Lyrica